Re-challenge chemotherapy in patients with sensitive relapse small-cell lung cancer and interstitial lung disease

BACKGROUND: Treatment modalities for small-cell lung cancer (SCLC) with pre-existing interstitial lung disease (ILD) are limited. Although re-challenge with first-line chemotherapy can be effective for sensitive relapse SCLC, its safety and efficacy are uncertain in cases with ILD. This study aimed...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Thorac Dis
Asıl Yazarlar: Nasu, Shingo, Suzuki, Hidekazu, Moriizumi, Kazunori, Hara, Yuki, Tanaka, Satoshi, Takada, Hiromune, Morita, Satomu, Tanaka, Ayako, Shiroyama, Takayuki, Morishita, Naoko, Okamoto, Norio, Hirashima, Tomonori
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AME Publishing Company 2019
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6409263/
https://ncbi.nlm.nih.gov/pubmed/30962995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.01.26
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller